Warby Parker (WRBY) Total Current Liabilities (2020 - 2026)
Warby Parker (WRBY) posted Total Current Liabilities of $153.3 million for Q1 2026, up 2.1% on a QoQ basis from $150.1 million in Q4 2025, and up 25.01% year-over-year from $122.6 million in Q1 2025.
Warby Parker (WRBY) Total Current Liabilities (2020 - 2026) Analysis & Trends
Warby Parker's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $153.3 million for Q1 2026.
- Quarterly Total Current Liabilities rose 25.01% year-over-year to $153.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.3 million (up 25.01% YoY) and the FY2025 annual result came in at $150.1 million, up 15.17% from the prior year.
- Total Current Liabilities was $153.3 million for Q1 2026 at Warby Parker, up from $150.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $153.3 million in Q1 2026 and bottomed at $110.4 million in Q2 2023.
- A 5-year average of $126.7 million and a median of $127.1 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities slipped 17.02% — and 2026, when it increased 25.01%.
- Warby Parker's Total Current Liabilities stood at $129.6 million in 2022, then retreated by 1.9% to $127.1 million in 2023, then rose by 2.57% to $130.4 million in 2024, then increased by 15.17% to $150.1 million in 2025, then advanced by 2.1% to $153.3 million in 2026.
- Business Quant data shows WRBY's Total Current Liabilities at $153.3 million in Q1 2026, $150.1 million in Q4 2025, and $132.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | 153.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153.28 Mn |
| Dec 31, 2025 | 150.13 Mn |
| Sep 30, 2025 | 132.07 Mn |
| Jun 30, 2025 | 135.53 Mn |
| Mar 31, 2025 | 122.61 Mn |
| Dec 31, 2024 | 130.35 Mn |
| Sep 30, 2024 | 130.12 Mn |
| Jun 30, 2024 | 121.03 Mn |
| Mar 31, 2024 | 118.54 Mn |
| Dec 31, 2023 | 127.09 Mn |
| Sep 30, 2023 | 121.81 Mn |
| Jun 30, 2023 | 110.43 Mn |
| Mar 31, 2023 | 111.04 Mn |
| Dec 31, 2022 | 129.56 Mn |
| Sep 30, 2022 | 111.48 Mn |
| Jun 30, 2022 | 119.86 Mn |
| Mar 31, 2022 | 128.74 Mn |
| Dec 31, 2021 | 118.10 Mn |
| Sep 30, 2021 | 134.36 Mn |
| Dec 31, 2020 | 105.33 Mn |